- Home
- LBTYK vs ACLX Comparison
LBTYK vs ACLX Comparison
Compare LBTYK & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LBTYK
- ACLX
- Stock Information
- Founded
- LBTYK 2004
- ACLX 2015
- Country
- LBTYK Bermuda
- ACLX United States
- Employees
- LBTYK N/A
- ACLX N/A
- Industry
- LBTYK Cable & Other Pay Television Services
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- LBTYK Telecommunications
- ACLX Health Care
- Exchange
- LBTYK Nasdaq
- ACLX Nasdaq
- Market Cap
- LBTYK 4.1B
- ACLX 4.4B
- IPO Year
- LBTYK N/A
- ACLX 2022
- Fundamental
- Price
- LBTYK $10.94
- ACLX $87.32
- Analyst Decision
- LBTYK
- ACLX Strong Buy
- Analyst Count
- LBTYK 0
- ACLX 9
- Target Price
- LBTYK N/A
- ACLX $117.78
- AVG Volume (30 Days)
- LBTYK 1.0M
- ACLX 381.7K
- Earning Date
- LBTYK 01-01-0001
- ACLX 11-05-2025
- Dividend Yield
- LBTYK N/A
- ACLX N/A
- EPS Growth
- LBTYK N/A
- ACLX N/A
- EPS
- LBTYK N/A
- ACLX N/A
- Revenue
- LBTYK $4,770,600,000.00
- ACLX $35,898,000.00
- Revenue This Year
- LBTYK $13.25
- ACLX N/A
- Revenue Next Year
- LBTYK $1.75
- ACLX $220.95
- P/E Ratio
- LBTYK N/A
- ACLX N/A
- Revenue Growth
- LBTYK 170.50
- ACLX N/A
- 52 Week Low
- LBTYK $9.21
- ACLX $47.86
- 52 Week High
- LBTYK $14.83
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- LBTYK 44.89
- ACLX 53.19
- Support Level
- LBTYK $10.76
- ACLX $85.00
- Resistance Level
- LBTYK $11.29
- ACLX $91.68
- Average True Range (ATR)
- LBTYK 0.38
- ACLX 3.99
- MACD
- LBTYK 0.02
- ACLX -0.16
- Stochastic Oscillator
- LBTYK 38.92
- ACLX 45.26
About LBTYK Liberty Global Ltd. Class C
Liberty Global is a holding company with interests in European telecom companies in the UK, the Netherlands, Belgium, Ireland, and Slovakia. Liberty owns the main cable network in each of these geographies and has pursued a strategy since 2016 to merge or partner with mobile network operators to be able to offer converged services. Liberty also owns minority stakes in other media, entertainment, and cloud companies.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.